Grid Dynamics Holdings, Inc. GDYN Healthcare and Pharma — Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Grid Dynamics Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Grid Dynamics Holdings, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue?
- Grid Dynamics Holdings, Inc. (GDYN) reported healthcare and pharma — revenue of $2.15M in Q1 2026.
- How has Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue changed year-over-year?
- Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue decreased by 10.4% year-over-year, from $2.41M to $2.15M.
- What is the long-term trend for Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue?
- Over 3 years (2022 to 2025), Grid Dynamics Holdings, Inc.'s healthcare and pharma — revenue has grown at a 9.7% compound annual growth rate (CAGR), from $7.71M to $10.18M.
- What does healthcare and pharma — revenue mean?
- This metric represents the total gross revenue generated specifically from digital transformation and technology consulting services provided to clients within the healthcare and pharmaceutical industry vertical. It reflects the company's ability to capture market share and deliver specialized technical solutions to organizations operating in this highly regulated sector. Tracking this revenue stream helps investors assess the company's diversification strategy and its success in penetrating the life sciences market.